DateSourceTitleList of Injuries
July 14, 2020New England Journal of MedicineAn mRNA Vaccine against SARS-CoV-2 – Preliminary ReportCardiac Disorders, Musculoskeletal and Connective Tissue Disorders, Nervous System Disorders, Respiratory, Thoracic and Mediastinal Disorders, Vascular Disorders, Eye Disorders, Ear and Labyrinth Disordersscreen
October 16, 2020JAMAPostapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the USAnaphylaxis, Guillain-Barré syndrome, Transverse myelitis, myocarditis / pericarditis, Vaccine-associated enhanced respiratory disease, Multisystem inflammatory syndrome in childrenscreen
October 30, 2020CDC’s ACIP Committee Meeting“CDC post-authorization/post-licensure safety monitoring of COVID-19 vaccines” by Tom Shimabukuro, MD, MPH, MBAAcute disseminated encephalomyelitis (ADEM), Acute myocardial infarction (AMI), Anaphylaxis, Acute respiratory distress syndrome (ARDS), Arthritis and arthralgia / joint pain, Convulsions / seizures, Disseminated intravascular coagulation (DIC), Encephalitis / myelitis / encephalomyelitis / meningoencephalitis / meningitis / encephalopathy (not ADEM or TM), Guillain-Barré syndrome (GBS), Immune thrombocytopenia (ITP), Kawasaki disease (KD), Multisystem Inflammatory Syndrome (MIS-C and MIS-A), Myocarditis / pericarditis, Narcolepsy / cataplexy, Stroke – hemorrhagic and ischemic, Transverse myelitis (TM), Venous thromboembolism (VTE)screen